Navigation Links
China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results
Date:9/1/2009

For the Years Ended March 31, March 31, 2008 2009 RMB RMB US$ (in thousands except for per ADS information) Revenues, net(1) 547,421 829,950 121,464 Cost of revenues (245,437) (219,337) (32,100) Gross profit 301,984 610,613 89,364 Operating expenses: Research and development (20,231) (31,450) (4,603) Acquired in-process research and development(3) (672) (244,872) (35,837) Sales and marketing (22,012) (55,956) (8,189) General and administrative(3) (70,939) (137,839) (20,173) Total operating expenses (113,854) (470,117) (68,802) Operating income (loss) 188,130 140,496 20,562 Other income 100 -- -- Interest income 28,650 32,354 4,735 Interest expense - convertible notes (39,149) (83,238) (12,182) Interest expense - amortization of convertible notes issuance costs (7,937) (14,387) (2,105) Interest expense - other (5,229) (4,240) (621) Income (loss) before income tax 164,565 70,985 10,389 Income tax expense (40,193) (73,042) (10,690) Income (loss) from continuing operations 124,372 (2,057) (301) Income from discontinued operation(2) 200,850 258,231
'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3New technique can help diagnose mesothelioma 55087 1New technique can help diagnose mesothelioma 55087 2U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 1U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 2Some brain tumors may be mediated by tiny filament on cells 9671 1Some brain tumors may be mediated by tiny filament on cells 9671 2Some brain tumors may be mediated by tiny filament on cells 9671 3Some brain tumors may be mediated by tiny filament on cells 9671 4